JP2023522630A5 - - Google Patents
Info
- Publication number
- JP2023522630A5 JP2023522630A5 JP2022562446A JP2022562446A JP2023522630A5 JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5 JP 2022562446 A JP2022562446 A JP 2022562446A JP 2022562446 A JP2022562446 A JP 2022562446A JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- amino acid
- antibody
- flt3
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063009578P | 2020-04-14 | 2020-04-14 | |
| US63/009,578 | 2020-04-14 | ||
| PCT/EP2021/059646 WO2021209495A1 (en) | 2020-04-14 | 2021-04-14 | Anti-flt3 antibodies and compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522630A JP2023522630A (ja) | 2023-05-31 |
| JP2023522630A5 true JP2023522630A5 (cg-RX-API-DMAC7.html) | 2024-04-22 |
| JP7679399B2 JP7679399B2 (ja) | 2025-05-19 |
Family
ID=75530015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562446A Active JP7679399B2 (ja) | 2020-04-14 | 2021-04-14 | 抗flt3抗体及び組成物 |
Country Status (17)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20230075A1 (es) * | 2020-04-14 | 2023-01-11 | Servier Lab | Anticuerpos anti-flt3 y composiciones |
| WO2024108163A2 (en) * | 2022-11-18 | 2024-05-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Molecules that bind to cd135 polypeptides |
| US20260217851A1 (en) * | 2022-12-22 | 2026-07-30 | The Medical College Of Wisconsin, Inc. | Compositions that Target CD138 and CD3 and Methods of Making and Using the Same |
| CN122055383A (zh) * | 2023-07-12 | 2026-05-15 | 费诺米人工智能公司 | 抗cthrc1 t细胞衔接体及其使用方法 |
| CN118924724B (zh) * | 2024-07-29 | 2025-11-04 | 湖南大学 | 一种用于治疗神经母细胞瘤的药物组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1186301B1 (en) | 1993-09-08 | 2006-08-16 | Imclone Systems, Inc. | Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| US5635388A (en) | 1994-04-04 | 1997-06-03 | Genentech, Inc. | Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| JP2002522063A (ja) | 1998-08-17 | 2002-07-23 | アブジェニックス インコーポレイテッド | 増加した血清半減期を有する改変された分子の生成 |
| WO2002066044A2 (en) | 2000-10-24 | 2002-08-29 | Immunex Corporation | Method for dendritic cells based immunotherapy of tumors using combination therapy |
| AR071891A1 (es) | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| ES2573642T3 (es) | 2009-12-23 | 2016-06-09 | Synimmune Gmbh | Anticuerpos anti-FLT3 y métodos de usar los mismos |
| KR20240056629A (ko) | 2014-09-28 | 2024-04-30 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 자극성 및 비자극성 골수성 세포의 조절 |
| TWI829617B (zh) * | 2015-07-31 | 2024-01-21 | 德商安美基研究(慕尼黑)公司 | Flt3及cd3抗體構築體 |
| EP3559038B1 (en) | 2016-12-21 | 2022-12-14 | The United States of America as represented by The Secretary Department of Health and Human Services | Human monoclonal antibodies specific for flt3 and uses thereof |
| PE20241587A1 (es) | 2017-06-02 | 2024-08-01 | Pfizer | Receptores de antigenos quimericos que se dirigen a flt3 |
| JP7234142B2 (ja) | 2017-06-02 | 2023-03-07 | ファイザー・インク | Flt3に特異的な抗体およびその使用 |
| EP3850010A1 (en) * | 2018-09-11 | 2021-07-21 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Improved anti-flt3 antigen binding proteins |
| EP3902836B1 (en) * | 2018-12-18 | 2026-03-25 | Boehringer Ingelheim IO Canada Inc. | Flt3 agonist antibodies and uses thereof |
| PE20230075A1 (es) * | 2020-04-14 | 2023-01-11 | Servier Lab | Anticuerpos anti-flt3 y composiciones |
-
2021
- 2021-04-14 PE PE2022002250A patent/PE20230075A1/es unknown
- 2021-04-14 CA CA3180188A patent/CA3180188A1/en active Pending
- 2021-04-14 EP EP21718860.6A patent/EP4136114A1/en active Pending
- 2021-04-14 BR BR112022020683A patent/BR112022020683A2/pt unknown
- 2021-04-14 KR KR1020227039594A patent/KR20220167331A/ko active Pending
- 2021-04-14 AU AU2021255884A patent/AU2021255884A1/en active Pending
- 2021-04-14 JP JP2022562446A patent/JP7679399B2/ja active Active
- 2021-04-14 WO PCT/EP2021/059646 patent/WO2021209495A1/en not_active Ceased
- 2021-04-14 US US17/230,289 patent/US12252539B2/en active Active
- 2021-04-14 CN CN202180042192.0A patent/CN115715297A/zh active Pending
- 2021-04-14 MX MX2022012919A patent/MX2022012919A/es unknown
- 2021-04-14 TW TW110113434A patent/TWI910146B/zh active
- 2021-04-14 IL IL297269A patent/IL297269A/en unknown
- 2021-04-14 PH PH1/2022/552710A patent/PH12022552710A1/en unknown
-
2022
- 2022-10-13 CO CONC2022/0014520A patent/CO2022014520A2/es unknown
- 2022-10-13 ZA ZA2022/11267A patent/ZA202211267B/en unknown
- 2022-10-14 CL CL2022002833A patent/CL2022002833A1/es unknown
-
2025
- 2025-02-07 US US19/048,584 patent/US20250179195A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107312091B (zh) | 靶向人cd19抗原的人源化单克隆抗体 | |
| CN105189562B (zh) | Il-15异源二聚体蛋白及其用途 | |
| JP2024527606A5 (cg-RX-API-DMAC7.html) | ||
| JP2021511811A5 (cg-RX-API-DMAC7.html) | ||
| Chen et al. | A bispecific antibody targeting HER2 and PD-L1 inhibits tumor growth with superior efficacy | |
| JP2021530207A (ja) | 二重特異性抗体及びその使用 | |
| JP2020109101A (ja) | 幹細胞増強治療法 | |
| JP2024521472A5 (cg-RX-API-DMAC7.html) | ||
| US11021538B2 (en) | Bispecific coupled antibody, preparation method and application thereof | |
| CN117050165B (zh) | 一种靶向猴痘病毒的抗体、其抗原结合片段及其用途 | |
| JP2022551662A (ja) | Bcmaを標的とする、ヒトサルの交差反応性を有するヒト化モノクローナル抗体 | |
| JP2020527158A (ja) | 多重特異性抗体混合物の生成およびその使用方法 | |
| JP2024516384A (ja) | 抗cntn4特異的抗体及びその使用 | |
| WO2021115303A1 (zh) | 一种抗Claudin18.2单克隆抗体、其制备方法及用途 | |
| JP2022008309A (ja) | Egfl6特異的モノクローナル抗体及びそれらの使用方法 | |
| TWI910146B (zh) | 抗flt3抗體及組合物 | |
| JP2024520577A5 (cg-RX-API-DMAC7.html) | ||
| CN117003897B (zh) | 靶向Claudin18.2的CAR-T细胞及其用途 | |
| CN118290584A (zh) | 一种包括nk细胞的药物组合物及其在制备治疗肿瘤药物中的应用 | |
| JP2023515821A5 (cg-RX-API-DMAC7.html) | ||
| CN113980133B (zh) | 抗体及其在抗肿瘤中的应用 | |
| CN114685675A (zh) | 双特异性抗体及其在治疗癌症中的用途 | |
| TW202019962A (zh) | 標靶CD38及TGF-β的組合療法 | |
| CN118047874A (zh) | 一种双特异性抗体及其与t细胞在制备治疗肿瘤药物中的应用 | |
| JP7162011B2 (ja) | 癌糖ペプチドに対するモノクローナルおよびヒト化抗体 |